Contact us

References

  1. European Union. ECIS – European Cancer Information System. From https://ecis.jrc.ec.europa.eu.
  2. Wu S-G, Zhang W-W, Sun J-Y, Li F-Y, Lin Q, He Z-Y. Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer. Front Oncol. 2018. doi:10.3389/fonc.2018.00302.
  3. Bernards N, Creemers GJ, Nieuwenhuijzen GAP, Bosscha K, Pruijt JFM, Lemmens VEPP. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol. 2013. doi:10.1093/annonc/mdt401.
  4. Kroese TE, Goense L, van Hillegersberg R, et al. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis. Dis Esophagus. June 2018. doi:10.1093/dote/doy055.
  5. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090-1098. doi:10.1016/S1470-2045(15)00040-6.
  6. Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget. 2015. doi:10.18632/oncotarget.3455.
  7. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8-10. doi:10.1200/JCO.1995.13.1.8.
  8. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8(6):378-382. doi:10.1038/nrclinonc.2011.44.
  9. Depypere L, Lerut T, Moons J, et al. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road. Dis Esophagus. 2017;30(1):1-8. doi:10.1111/dote.12508.
  10. Seesing MFJ, van der Veen A, Brenkman HJF, et al. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study. Dis Esophagus. April 2019. doi:10.1093/dote/doz034.
  11. Al-Batran S-E, Homann N, Pauligk C, et al. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer. JAMA Oncol. 2017;3(9):1237. doi:10.1001/jamaoncol.2017.0515.
  12. Mariette C. Palliative Gastric Resection Plus Chemotherapy Versus Chemotherapy Alone in Stage IV Gastric Cancer. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03042169. Accessed July 11, 2019.
  13. Al-Batran S-E, Goetze TO, Mueller DW, et al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI. BMC Cancer. 2017;17(1):893. doi:10.1186/s12885-017-3918-9.
  14. Nguyen Q-N. Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03161522. Accessed July 11, 2019.
  15. Staff J, Owners DJ, Freedom E, et al. Vancouver recommendations 2018. 2018;(December):1-19. www.equator-network.org.